rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2003-7-30
|
pubmed:abstractText |
Following successful angioplasty of 49 saphenous vein graft lesions, a novel, self-centering phosphorus-32 solid foil beta source encapsulated within a dual-balloon membrane was used to deliver 20 Gy 1 mm into the vessel wall. Clinical and angiographic recurrence rates at 12 months were low, especially in de novo lesions.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0002-9149
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
312-4
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12888142-Aged,
pubmed-meshheading:12888142-Beta Particles,
pubmed-meshheading:12888142-Brachytherapy,
pubmed-meshheading:12888142-Equipment Design,
pubmed-meshheading:12888142-Female,
pubmed-meshheading:12888142-Follow-Up Studies,
pubmed-meshheading:12888142-Graft Occlusion, Vascular,
pubmed-meshheading:12888142-Humans,
pubmed-meshheading:12888142-Male,
pubmed-meshheading:12888142-Saphenous Vein,
pubmed-meshheading:12888142-Stents,
pubmed-meshheading:12888142-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts.
|
pubmed:affiliation |
Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA. gstone@crf.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|